dipivefrin


Also found in: Acronyms.

dipivefrin

 [di-piv´ah-frin]
an ester converted in the eye to epinephrine, lowering intraocular pressure by decreasing the production and increasing the outflow of aqueous humor; the hydrochloride salt is applied topically to the conjunctiva in treatment of open-angle or secondary glaucoma.

dipivefrin

/di·piv·e·frin/ (di-piv´ah-frin) an ester converted in the eye to epinephrine, lowering intraocular pressure by decreasing the production and increasing the outflow of aqueous humor; the hydrochloride salt is applied topically in the treatment of open-angle or secondary glaucoma.

dipivefrin

[dī′pivef′rin]
an ophthalmic sympathomimetic agent.
indication It is prescribed in the treatment of open-angle glaucoma.
contraindications Narrow-angle glaucoma or known hypersensitivity to this drug prohibits its use.
adverse effects Among the most serious adverse effects are reactive hyperemia, conjunctivitis, allergic reactions, macular edema, tachycardia, arrhythmia, and hypertension.

dipivefrin

A SYMPATHOMIMETIC drug used to treat open angle GLAUCOMA. A brand name is Propine.

dipivefrin

an epinephrine prodrug used as the hydrochloride in ophthalmic drops to treat open-angle glaucoma.
References in periodicals archive ?
You should alert your health care professional if you have eye diseases or problems in addition to glaucoma when taking dipivefrin because the drug can aggravate them.
Topical adrenaline and the adrenaline precursor dipivefrin lower IOP They probably act on pre-synaptic [Alpha]-2 adrenoceptors on the ciliary body [21].
Dipivefrin and epinephrine treatment of elevated intraocular pressure.
His medications included theophylline, prednisone, inhaled beclomethasone dipropionate and metaproterenol sulfate, verapamil hydrochloride, oxybutynin chloride, ophthalmic dipivefrin hydrochloride, and topical metronidazole.
today announced that both Dipivefrin Hydrochloride 0.
Pharmaceutical Division has received clearance to begin marketing Dipivefrin Hydrochloride Ophthalmic Solution USP, 0.